Pathios nabs $8.8 mln Series A

UK-based Pathios, a biotech company focused on treating autoimmune diseases and cancer, has raised $8.8 million in Series A financing.

UK-based Pathios, a biotech company focused on treating autoimmune diseases and cancer, has raised $8.8 million in Series A financing. The investors were Canaan and Australia’s Medical Research Commercialisation Fund managed by Brandon Capital.

Source: Press Release